
Vered Stearns MD
Breast Cancer, Hematologic Oncology
Professor of Oncology, Weill Cornell Medicine, Meyer Cancer Center
Request Appointment
5255 Loughboro Rd NWWashington, DC 20016
Overview of Dr. Stearns
Dr. Vered Stearns is an oncologist in New York. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 25 years. She also speaks multiple languages, including Hebrew. She specializes in breast cancer and hematologic oncology and is experienced in breast cancer treatment and translational research. She has more than 100 publications and over 500 citings.
Education & Training
- MedStart Georgetown University HospitalFellowship, Medical Oncology, 1995 - 1997
- MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 1992 - 1995
- Rutgers Robert Wood Johnson Medical SchoolClass of 1992
Certifications & Licensure
- FL State Medical License 2021 - Present
- DC State Medical License 1996 - 2027
- NY State Medical License 2023 - 2027
- MD State Medical License 2002 - 2025
- MI State Medical License 2001 - 2005
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer Start of enrollment: 1997 Mar 01
- Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer Start of enrollment: 2003 Aug 11
- Aromatase Inhibitor Clinical Trial Start of enrollment: 2005 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer: Secondary Analysis of the Breast Cancer Weight Loss (BWEL) Trial.Jennifer A Ligibel, Karla V Ballman, Linda McCall, Pamela J Goodwin, Catherine M Alfano
JAMA Oncology. 2025-08-21 - Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta, John M S Bartlett, Tammy Piper
Breast Cancer Research and Treatment. 2025-08-01 - Patient navigator training for sexual orientation and gender identity data collection at an NCI-Designated Comprehensive Cancer Center.Kristi Tredway, Elizabeth Saylor, Vered Stearns
Journal of the National Cancer Institute. Monographs. 2025-07-01
Press Mentions
- CDC Allocates Funds to Support Initiatives Aimed at Breast Cancer PatientsJanuary 6th, 2025
- Behind the Study: Weight Loss Strategies for Breast Cancer SurvivorsMarch 3rd, 2022
- Battling Breast Cancer Year-Round: Why Breast Cancer Awareness Should Continue Even After OctoberOctober 30th, 2021
- Join now to see all
Grant Support
- The Effects Of 24 Months Of Exemestane Or Letrozole On Surrogate MarkersNational Center For Research Resources2007
Professional Memberships
- Member
Other Languages
- Hebrew
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/vered-stearns
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California PPO
BCBS North Carolina BlueOptions PPO
CareFirst BlueChoice Advantage
CareFirst BlueChoice Network POS
CareFirst BluePreferred PPO
CIGNA HMOCIGNA Open Access
CIGNA PPO
Cofinity PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: